Elevance Health Statistics
Total Valuation
Elevance Health has a market cap or net worth of $90.76 billion. The enterprise value is $111.17 billion.
| Market Cap | 90.76B |
| Enterprise Value | 111.17B |
Important Dates
The last earnings date was Wednesday, October 21, 2026, before market open.
| Earnings Date | Oct 21, 2026 |
| Ex-Dividend Date | Dec 4, 2026 |
Share Statistics
Elevance Health has 216.06 million shares outstanding. The number of shares has decreased by -3.33% in one year.
| Current Share Class | 216.06M |
| Shares Outstanding | 216.06M |
| Shares Change (YoY) | -3.33% |
| Shares Change (QoQ) | -0.14% |
| Owned by Insiders (%) | 0.11% |
| Owned by Institutions (%) | 95.59% |
| Float | 215.57M |
Valuation Ratios
The trailing PE ratio is 17.92 and the forward PE ratio is 14.59. Elevance Health's PEG ratio is 3.77.
| PE Ratio | 17.92 |
| Forward PE | 14.59 |
| PS Ratio | 0.45 |
| Forward PS | 0.45 |
| PB Ratio | 2.03 |
| P/TBV Ratio | 16.62 |
| P/FCF Ratio | 13.93 |
| P/OCF Ratio | 11.95 |
| PEG Ratio | 3.77 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 12.76, with an EV/FCF ratio of 17.07.
| EV / Earnings | 21.63 |
| EV / Sales | 0.55 |
| EV / EBITDA | 12.76 |
| EV / EBIT | 13.85 |
| EV / FCF | 17.07 |
Financial Position
The company has a current ratio of 1.47, with a Debt / Equity ratio of 0.69.
| Current Ratio | 1.47 |
| Quick Ratio | 1.34 |
| Debt / Equity | 0.69 |
| Debt / EBITDA | 3.47 |
| Debt / FCF | 4.72 |
| Interest Coverage | 5.55 |
Financial Efficiency
Return on equity (ROE) is 11.48% and return on invested capital (ROIC) is 8.65%.
| Return on Equity (ROE) | 11.48% |
| Return on Assets (ROA) | 4.00% |
| Return on Invested Capital (ROIC) | 8.65% |
| Return on Capital Employed (ROCE) | 9.89% |
| Weighted Average Cost of Capital (WACC) | 7.07% |
| Revenue Per Employee | $2.08M |
| Profits Per Employee | $52,925 |
| Employee Count | 97,100 |
| Asset Turnover | 1.61 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Elevance Health has paid $1.15 billion in taxes.
| Income Tax | 1.15B |
| Effective Tax Rate | 18.35% |
Stock Price Statistics
The stock price has increased by +24.89% in the last 52 weeks. The beta is 0.71, so Elevance Health's price volatility has been lower than the market average.
| Beta (5Y) | 0.71 |
| 52-Week Price Change | +24.89% |
| 50-Day Moving Average | 410.56 |
| 200-Day Moving Average | 372.35 |
| Relative Strength Index (RSI) | 50.77 |
| Average Volume (20 Days) | 1,345,801 |
Short Selling Information
The latest short interest is 5.14 million, so 2.38% of the outstanding shares have been sold short.
| Short Interest | 5.14M |
| Short Previous Month | 5.34M |
| Short % of Shares Out | 2.38% |
| Short % of Float | 2.38% |
| Short Ratio (days to cover) | 4.04 |
Income Statement
In the last 12 months, Elevance Health had revenue of $201.83 billion and earned $5.14 billion in profits. Earnings per share was $23.44.
| Revenue | 201.83B |
| Gross Profit | 53.35B |
| Operating Income | 8.03B |
| Pretax Income | 6.25B |
| Net Income | 5.14B |
| EBITDA | 8.71B |
| EBIT | 8.03B |
| Earnings Per Share (EPS) | $23.44 |
Balance Sheet
The company has $37.85 billion in cash and $30.76 billion in debt, with a net cash position of -$20.41 billion or -$94.46 per share.
| Cash & Cash Equivalents | 37.85B |
| Total Debt | 30.76B |
| Net Cash | -20.41B |
| Net Cash Per Share | -$94.46 |
| Equity (Book Value) | 44.79B |
| Book Value Per Share | 206.75 |
| Working Capital | 21.86B |
Cash Flow
In the last 12 months, operating cash flow was $7.60 billion and capital expenditures -$1.08 billion, giving a free cash flow of $6.51 billion.
| Operating Cash Flow | 7.60B |
| Capital Expenditures | -1.08B |
| Depreciation & Amortization | n/a |
| Net Borrowing | 588.00M |
| Free Cash Flow | 6.51B |
| FCF Per Share | $30.15 |
Margins
Gross margin is 26.43%, with operating and profit margins of 3.98% and 2.55%.
| Gross Margin | 26.43% |
| Operating Margin | 3.98% |
| Pretax Margin | 3.10% |
| Profit Margin | 2.55% |
| EBITDA Margin | 4.32% |
| EBIT Margin | 3.98% |
| FCF Margin | 3.23% |
Dividends & Yields
This stock pays an annual dividend of $6.88, which amounts to a dividend yield of 1.64%.
| Dividend Per Share | $6.88 |
| Dividend Yield | 1.64% |
| Dividend Growth (YoY) | 0.58% |
| Years of Dividend Growth | 14 |
| Payout Ratio | 29.36% |
| FCF Payout Ratio | 22.82% |
| Buyback Yield | 3.33% |
| Shareholder Yield | 4.97% |
| Earnings Yield | 5.58% |
| FCF Yield | 7.18% |
Analyst Forecast
The average price target for Elevance Health is $482.38, which is 14.83% higher than the current price. The consensus rating is "Buy".
| Price Target | $482.38 |
| Price Target Difference | 14.83% |
| Analyst Consensus | Buy |
| Analyst Count | 22 |
| Revenue Growth Forecast (3Y) | 2.14% |
| EPS Growth Forecast (3Y) | 4.50% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on June 1, 2005. It was a forward split with a ratio of 2:1.
| Last Split Date | Jun 1, 2005 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 5 |